Positive. Top analyst reports highlight strong performance and growth potential for Microsoft, Exxon Mobil, and Amgen.

From Nasdaq: 2025-01-06 16:12:00

Today’s Zacks Research Daily highlights new reports on 16 major stocks, including Microsoft Corp. (MSFT), Exxon Mobil Corp. (XOM), and Amgen Inc. (AMGN). Microsoft is benefiting from strong Azure and Office 365 performance, while Exxon Mobil’s high-value assets are driving robust production growth. Amgen faces pricing headwinds but key drugs are expected to drive sales. PrimeEnergy Resources and FONAR Corp. are two micro-cap stocks with unique research reports. PrimeEnergy Resources has seen a surge in revenues driven by higher production volumes and strategic investments, while FONAR Corp. faces challenges with declining net income and cash flow constraints.

Microsoft’s Intelligent Cloud revenues are driven by growth in Azure and other cloud services, with fiscal 2025 net sales expected to grow 12.8% from fiscal 2024. However, declining commercial licensing and competition in the cloud space remain concerns. Exxon Mobil’s shares have outperformed the Zacks Oil and Gas – Integrated – International industry, with the company’s high-value assets driving robust production growth. Amgen’s shares have underperformed the Zacks Medical – Biomedical and Genetics industry, facing pricing headwinds and competitive pressure. Key drugs are expected to drive sales. PrimeEnergy Resources’ shares have outperformed the Zacks Oil and Gas – Exploration and Production – U.S. industry, showcasing a surge in revenues driven by higher production volumes and strategic investments. FONAR Corp. has seen challenges with declining net income and cash flow constraints, emphasizing the need for cost control and geographic diversification.

Other noteworthy reports include Lowe’s Companies, Inc. (LOW), U.S. Bancorp (USB), and HCA Healthcare, Inc. (HCA). Lowe’s pro customer strategy and omni-channel efforts are expected to boost sales, while organic growth supports U.S. Bancorp amid high costs. HCA Healthcare’s growing revenues, driven by increasing admissions, have led to significant growth. Strategic acquisitions have helped it expand and remain a driving factor.

Featured reports also include Heico (HEI), NVR, Inc. (NVR), and HealthEquity (HQY). Heico’s disciplined acquisition strategy is expected to drive performance, while NVR benefits from growth in new orders and higher settlements. HealthEquity continues to witness growth in HSAs, despite data security threats. New upgrades include BNY Mellon (BK) and Alkermes (ALKS), while new downgrades include Alkermes and CommScope (COMM).

To read the full research reports on these companies and more, visit Zacks.com.



Read more at Nasdaq: Top Analyst Reports for Microsoft, Exxon Mobil & Amgen